Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8478 | 1180 | 32.2 | 42% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2793 | 2583 | TUMOR DORMANCY//DORN VA MED//CONCOMITANT RESISTANCE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TUMOR BEARING STATE | Author keyword | 4 | 67% | 0% | 4 |
| 2 | AUTOIMMUNOTHERAPY | Author keyword | 1 | 100% | 0% | 2 |
| 3 | CD8 CELL REACTIVITY | Author keyword | 1 | 100% | 0% | 2 |
| 4 | ALLOGENEIC ANTIGEN | Author keyword | 1 | 50% | 0% | 1 |
| 5 | ANTITUMOR CYTOTOXIC LYMPHOCYTES | Author keyword | 1 | 50% | 0% | 1 |
| 6 | CD 4 T CELLS | Author keyword | 1 | 50% | 0% | 1 |
| 7 | CHEMICAL XENOGENIZATION | Author keyword | 1 | 50% | 0% | 1 |
| 8 | CULTURED T CELLS | Author keyword | 1 | 50% | 0% | 1 |
| 9 | IMMUNOSENSITIVITY | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ISOLATION AND ANALYSIS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TUMOR BEARING STATE | 4 | 67% | 0% | 4 | Search TUMOR+BEARING+STATE | Search TUMOR+BEARING+STATE |
| 2 | AUTOIMMUNOTHERAPY | 1 | 100% | 0% | 2 | Search AUTOIMMUNOTHERAPY | Search AUTOIMMUNOTHERAPY |
| 3 | CD8 CELL REACTIVITY | 1 | 100% | 0% | 2 | Search CD8+CELL+REACTIVITY | Search CD8+CELL+REACTIVITY |
| 4 | ALLOGENEIC ANTIGEN | 1 | 50% | 0% | 1 | Search ALLOGENEIC+ANTIGEN | Search ALLOGENEIC+ANTIGEN |
| 5 | ANTITUMOR CYTOTOXIC LYMPHOCYTES | 1 | 50% | 0% | 1 | Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES | Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES |
| 6 | CD 4 T CELLS | 1 | 50% | 0% | 1 | Search CD+4+T+CELLS | Search CD+4+T+CELLS |
| 7 | CHEMICAL XENOGENIZATION | 1 | 50% | 0% | 1 | Search CHEMICAL+XENOGENIZATION | Search CHEMICAL+XENOGENIZATION |
| 8 | CULTURED T CELLS | 1 | 50% | 0% | 1 | Search CULTURED+T+CELLS | Search CULTURED+T+CELLS |
| 9 | IMMUNOSENSITIVITY | 1 | 50% | 0% | 1 | Search IMMUNOSENSITIVITY | Search IMMUNOSENSITIVITY |
| 10 | ISOLATION AND ANALYSIS | 1 | 50% | 0% | 1 | Search ISOLATION+AND+ANALYSIS | Search ISOLATION+AND+ANALYSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ESTABLISHED LEUKEMIA | 4 | 75% | 0% | 3 |
| 2 | IMMUNE LYMPHOCYTES | 2 | 67% | 0% | 2 |
| 3 | IMMUNOGENIC CHANGES | 2 | 67% | 0% | 2 |
| 4 | LYT 12 T CELLS | 2 | 67% | 0% | 2 |
| 5 | P815AB | 2 | 67% | 0% | 2 |
| 6 | ADOPTIVE CHEMO IMMUNOTHERAPY | 2 | 50% | 0% | 3 |
| 7 | SYNGENEIC TUMOR | 2 | 29% | 1% | 6 |
| 8 | MASTOCYTOMA P815 | 2 | 36% | 0% | 4 |
| 9 | CHEMICALLY XENOGENIZED TUMORS | 1 | 100% | 0% | 2 |
| 10 | L5178Y LYMPHOMA | 1 | 100% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| ADOPTIVE T-CELL THERAPY OF TUMORS - MECHANISMS OPERATIVE IN THE RECOGNITION AND ELIMINATION OF TUMOR-CELLS | 1991 | 533 | 289 | 17% |
| DOWN-REGULATION OF THE ANTITUMOR IMMUNE-RESPONSE | 1985 | 173 | 60 | 55% |
| ANTITUMOR IMMUNE-RESPONSES OF THE TUMOR-BEARING HOST - THE CASE FOR ANTIBODY-MEDIATED IMMUNOLOGICAL ENHANCEMENT | 1994 | 21 | 17 | 65% |
| TUMOR-ERADICATION BY ADOPTIVE TRANSFER OF CYTOTOXIC T-LYMPHOCYTES | 1992 | 237 | 194 | 20% |
| TOWARD A GENETIC-ANALYSIS OF TUMOR REJECTION ANTIGENS | 1992 | 125 | 84 | 30% |
| UNIQUE TUMOR-SPECIFIC ANTIGENS | 1988 | 70 | 41 | 46% |
| PHENOTYPICALLY AND FUNCTIONALLY DISTINCT T-CELL SUBSETS IN ANTITUMOR RESPONSES | 1987 | 44 | 22 | 55% |
| ANTIGENIC TUMOR-CELL VARIANTS OBTAINED WITH MUTAGENS | 1983 | 155 | 37 | 70% |
| THE MURINE ANTITUMOR IMMUNE-RESPONSE AND ITS THERAPEUTIC MANIPULATION | 1984 | 187 | 30 | 47% |
| THERAPY OF DISSEMINATED TUMORS BY ADOPTIVE TRANSFER OF SPECIFICALLY IMMUNE T-CELLS | 1988 | 41 | 41 | 54% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED IMMUNOL TB CANC | 1 | 50% | 0.1% | 1 |
| 2 | IMMUNOL TB CANC | 0 | 33% | 0.1% | 1 |
| 3 | PHTHISIOPULM | 0 | 25% | 0.1% | 1 |
| 4 | STROM THURMOND BIOMED | 0 | 25% | 0.1% | 1 |
| 5 | EXPTL BIOL MED BIJENICKA 54 | 0 | 20% | 0.1% | 1 |
| 6 | SURG 4 TRANSPLANTAT | 0 | 20% | 0.1% | 1 |
| 7 | IMMUNOLMINATO KU | 0 | 14% | 0.1% | 1 |
| 8 | TB CANC IMMUNOL | 0 | 14% | 0.1% | 1 |
| 9 | CONTRACT JEUNE FORMAT 948 | 0 | 100% | 0.1% | 1 |
| 10 | DENT ORAL SURG 2 HIGASHI KU | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000227672 | ACUTE MORBILLI INFECTION//// |
| 2 | 0.0000204872 | ANTIGEN SHEDDING//ADOPTIVE CHEMOIMMUNOTHERAPY//DRUG RESISTANT TUMORS |
| 3 | 0.0000181862 | TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY |
| 4 | 0.0000171201 | MU MSV//CLA PTX//EPIDERMIS PROLIFERATION |
| 5 | 0.0000129759 | WARD COLON TUMOR//MAIF//MAMMARY TUMOR BEARERS |
| 6 | 0.0000114985 | ALLOANTIGEN SPECIFIC CYTOTOXIC T LYMPHOCYTES//ALPHA BETA TCR TRANSGENE//FOOTPAD IMMUNIZATION |
| 7 | 0.0000095521 | VIRAL ONCOLYSATE//CELLULAR IMMUNOL D010//MTH 68 H |
| 8 | 0.0000094302 | XYMEDON//ANTIGEN PURIFICATION//BIOL KAZAN |
| 9 | 0.0000081036 | INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2 |
| 10 | 0.0000075442 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |